PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Aprepitant
Presentation Product Chemical substance Chapter Items dispensed
Aprepitant 80mg capsules
0406000ADAAAAAA
Aprepitant Aprepitant Central Nervous System 50
Aprepitant 125mg capsules and Aprepitant 80mg capsules
0406000ADAAACAC
Aprepitant Aprepitant Central Nervous System 12
Emend 125mg and 80mg capsules
0406000ADBBACAC
Emend Aprepitant Central Nervous System 4
Aprepitant 125mg capsules
0406000ADAAABAB
Aprepitant Aprepitant Central Nervous System 3
Aprepitant 25mg/5ml oral suspension
0406000ADAAAEAE
Aprepitant Aprepitant Central Nervous System 2
Emend 80mg capsules
0406000ADBBAAAA
Emend Aprepitant Central Nervous System 2
Aprepitant 125mg oral powder sachets
0406000ADAAAGAG
Aprepitant Aprepitant Central Nervous System 1
Aprepitant 30mg/5ml oral suspension
0406000ADAAAFAF
Aprepitant Aprepitant Central Nervous System No data available
Aprepitant 40mg/5ml oral suspension
0406000ADAAADAD
Aprepitant Aprepitant Central Nervous System No data available
Emend 125mg capsules
0406000ADBBABAB
Emend Aprepitant Central Nervous System No data available
Emend 125mg oral powder sachets
0406000ADBBADAG
Emend Aprepitant Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.